Viewing Study NCT00065156


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-01-09 @ 4:24 PM
Study NCT ID: NCT00065156
Status: COMPLETED
Last Update Posted: 2019-11-19
First Post: 2003-07-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View
None CC-5013 View
None Revlimid View
None Celgene View